{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/59572-775#drug","name":"Reblozyl","alternateName":"Luspatercept","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"59572-775"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761136"},{"@type":"PropertyValue","propertyID":"UNII","value":"AQK7UBA1LS"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"82f4d266-3f52-41eb-86ba-0abf3cf468e8"}],"activeIngredient":"LUSPATERCEPT","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Celgene Corporation"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761136","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82f4d266-3f52-41eb-86ba-0abf3cf468e8","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-775"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T16:30:43.638Z"}}